Inhibikase Therapeutics Inc. Insider Trading
IKT
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Oct 2024.
Get an email when IKT's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Frank M. Sands Large holder | Bought | 2,068,965 | $1.45 | $3M | 19% | Form 4 |
- Nov 21, 2025Frank M. SandsLarge holder · bought 2,068,965 at $1.45$3M19% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with IKT
Held by ETFs
IKT is in 3 US ETFs. The largest of them, with IKT's weight in each:
Spot a number that looks wrong? Check it in IKT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing IKT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.